Open AccessAdverse Events After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease
Author(s) -
Gregory J. Botwin,
Dalin Li,
Jane C. Figueiredo,
Susan Cheng,
Jonathan Braun,
Dermot P. McGovern,
Gil Y. Melmed
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000001342
Subject(s) - medicine , inflammatory bowel disease , vaccination , adverse effect , immune system , immunology , disease , population , coronavirus , covid-19 , infectious disease (medical specialty) , environmental health
Patients with immune-mediated inflammatory diseases such as inflammatory bowel disease (IBD) on immunosuppressive and biologic therapies were largely excluded from severe acute respiratory syndrome coronavirus-2 messenger RNA vaccine trials.